Dermata Therapeutics Inc (DRMA NASDAQ) stock market data APIs
$1.1874
0.04(3.4%)
as of May 15, 2026
Try our APIs with
free plan!
Dermata Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Prev. Close
1.1874
Open
1.2279
High
1.2282
Low
1.1802
52 wk Range
1.1-8.5
Market Cap
4 786 K
Shares Outstanding
4 022 K
EPS
-0.48
Beta
0.673
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dermata Therapeutics Inc data using free add-ons & libraries
Get Dermata Therapeutics Inc Fundamental Data
Dermata Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -7 856 542
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Dermata Therapeutics Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -0.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dermata Therapeutics Inc News
New
Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln
(RTTNews) - Dermata Therapeutics Inc. (DRMA), a dermatologic firm, announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2.02 million shares of common s...
Dermata Therapeutics announces up to $12.4 million private placement
* Dermata Therapeutics (DRMA [https://seekingalpha.com/symbol/DRMA]) has entered into definitive agreements for the issuance and sale of an aggregate of 2.02M shares of common stock, series C warran...
Dermata Therapeutics GAAP EPS of -$1.65
* Dermata Therapeutics press release [https://seekingalpha.com/pr/20308632-dermata-therapeutics-provides-corporate-update-and-reports-third-quarter-2025-financial] (DRMA [https://seekingalpha.com/sy...
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Invest...
Get Dermata Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
